Gut Microbiota-Medication Interaction in Rheumatic Diseases
- PMID: 34925383
- PMCID: PMC8678121
- DOI: 10.3389/fimmu.2021.796865
Gut Microbiota-Medication Interaction in Rheumatic Diseases
Abstract
Besides its contribution to the development of rheumatic diseases, the gut microbiota interact with anti-rheumatic drugs. The intestinal microbiota can directly metabolize many drugs and indirectly change drug metabolism through a complex multi-dimensional interaction with the host, thus affecting individual response to drug therapy and adverse effects. The focus of the current review is to address recent advances and important progress in our understanding of how the gut microbiota interact with anti-rheumatic drugs and provide perspectives on promoting precision treatment, drug discovery, and better therapy for rheumatic diseases.
Keywords: biomarkers; disease modifying anti-rheumatic drugs; microbiota; personalized medicine; prediction and opportunity.
Copyright © 2021 Zhang and Chu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

References
-
- Martinez-Martinez RE, Abud-Mendoza C, Patino-Marin N, Rizo-Rodriguez JC, Little JW, Loyola-Rodriguez JP. Detection of Periodontal Bacterial DNA in Serum and Synovial Fluid in Refractory Rheumatoid Arthritis Patients. J Clin Periodontol (2009) 36(12):1004–10. doi: 10.1111/j.1600-051X.2009.01496.x - DOI - PubMed
-
- de Pablo P, Dietrich T, McAlindon TE. Association of Periodontal Disease and Tooth Loss With Rheumatoid Arthritis in the US Population. J Rheumatol (2008) 35(1):70–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources